Yahoo Web Search

Search results

    • Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 19 hours ago

      Let's start there. I'm pleased to share that we've completed enrollment in the pediatric trial with ORLADEYO, which includes extending dosing in children down to two years of age. This means ...